Tendly Chat - AI Procurement Intelligence

Procurement of 17 intensive care ventilators

Hochtaunus Kliniken gGmbH·Ref T-965304182·via Bekanntmachungsservice

VALUE

--

DEADLINE

Nov 23, 2026

TIME LEFT

32 days

EUREGIO-KLINIK Nordhorn - New Angiography Building - Delivery and Installation of a Biplane Angiography System

EUREGIO-KLINIK Albert-Schweitzer-Straße GmbH·Ref T-715241990·via Bekanntmachungsservice

VALUE

€1.5M

DEADLINE

Nov 23, 2026

TIME LEFT

32 days

Medical furniture LV.381

Klinikum Fürth·Ref T-1035929418·via Bekanntmachungsservice

VALUE

--

DEADLINE

Nov 24, 2026

TIME LEFT

33 days

36. Generic tender (1st)

GWQ ServicePlus AG Gesellschaft für Wirtschaftlichkeit und Qualität bei Krankenkassen·Ref T-1635442824·via Bekanntmachungsservice

VALUE

--

DEADLINE

Nov 25, 2026

TIME LEFT

34 days

36. Generics tender (2/3)

GWQ ServicePlus AG·Ref T-2145776275·via Bekanntmachungsservice

VALUE

--

DEADLINE

Nov 25, 2026

TIME LEFT

34 days

36. Generic tender (antibiotics)

GWQ ServicePlus AG·Ref T-1040022407·via Bekanntmachungsservice

VALUE

--

DEADLINE

Nov 25, 2026

TIME LEFT

34 days

Open House Original Discount Contracts 2025-19 - Tafamidis

Techniker Krankenkasse·Ref T-420666615·via Bekanntmachungsservice

VALUE

--

DEADLINE

Nov 30, 2026

TIME LEFT

39 days

Open House Original Discount Contracts 2025-05 - Emtricitabine/Tenofovir disoproxil/Rilpivirine (drug combination)

Techniker Krankenkasse·Ref T-298730733·via Bekanntmachungsservice

VALUE

--

DEADLINE

Nov 30, 2026

TIME LEFT

39 days

Conclusion of non-exclusive drug discount agreements according to § 130a para. 8 SGB V by means of an open house model for the active ingredient pancreatin (WHO ATC code: A09AA02)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Ref T-543310606·via Bekanntmachungsservice

VALUE

--

DEADLINE

Nov 30, 2026

TIME LEFT

39 days

Open-House-Biologika-Discount-Contracts 2025-25 - Aflibercept (ATC: S01LA05; Strength: 40 mg/ml)

Techniker Krankenkasse·Ref T-756891869·via Bekanntmachungsservice

VALUE

--

DEADLINE

Nov 30, 2026

TIME LEFT

39 days

Conclusion not excl. Arzneimittel-Rabattvereinb. according to § 130a Abs. 8 SGB V in the form of an open-house model for the active ingredient Certolizumab pegol (ATC code according to WHO: L04AB05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Ref T-264518545·via Bekanntmachungsservice

VALUE

--

DEADLINE

Dec 31, 2026

TIME LEFT

70 days

Open house drug discount contracts for the active ingredient Dimethyl Fumarate, ATC L04AX07

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Ref T-638049579·via Bekanntmachungsservice

VALUE

--

DEADLINE

Jan 31, 2027

TIME LEFT

101 days

Conclusion of a non-exclusive discount agreement according to § 130a para. 8 SGB V for the active ingredient Guselkumab (exclusively strength 100mg), ATC L04AC16 for the period 01.12.2026 - 31.03.2027

DAK-Gesundheit·Ref T-100581304·via Bekanntmachungsservice

VALUE

€1

DEADLINE

Feb 5, 2027

TIME LEFT

106 days

Conclusion of a non-exclusive discount agreement according to § 130a para. 8 SGB V for the active ingredient Bimekizumab, ATC L04AC21 for the period 01.10.2026 - 31.03.2027

DAK-Gesundheit·Ref T-1443689617·via Bekanntmachungsservice

VALUE

€1

DEADLINE

Feb 5, 2027

TIME LEFT

106 days

Open-house drug discount agreements according to § 130a para. 8c SGB V for the KV region Berlin

AOK Nordost. Die Gesundheitskasse.·Ref T-104697664·via Bekanntmachungsservice

VALUE

--

DEADLINE

Feb 21, 2027

TIME LEFT

122 days

Open-house drug discount agreements according to § 130a para. 8c SGB V for the KV region Mecklenburg-Vorpommern

AOK Nordost. Die Gesundheitskasse.·Ref T-945347902·via Bekanntmachungsservice

VALUE

--

DEADLINE

Feb 21, 2027

TIME LEFT

122 days

Open-house drug discount agreements according to § 130a para. 8c SGB V for the KV region Brandenburg

AOK Nordost. Die Gesundheitskasse.·Ref T-807951360·via Bekanntmachungsservice

VALUE

--

DEADLINE

Feb 21, 2027

TIME LEFT

122 days

Open-house discount agreements 2025-01

Techniker Krankenkasse·Ref T-2091310200·via Bekanntmachungsservice

VALUE

--

DEADLINE

Feb 28, 2027

TIME LEFT

129 days

Conclusion not excl. drug rebate agreements according to § 130a para. 8 SGB V by means of an open-house model for the active ingredient Oxycodone/Naloxone (WHO ATC code: N02AA55)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Ref T-1384841192·via Bekanntmachungsservice

VALUE

--

DEADLINE

Mar 31, 2027

TIME LEFT

160 days

Open House Discount Contracts 2025-02

Techniker Krankenkasse·Ref T-63199494·via Bekanntmachungsservice

VALUE

--

DEADLINE

Mar 31, 2027

TIME LEFT

160 days

Open house drug discount contracts for the active ingredient Ticagrelor, ATC B01AC24

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Ref T-367233372·via Bekanntmachungsservice

VALUE

--

DEADLINE

Mar 31, 2027

TIME LEFT

160 days

Open house discount agreements for the active ingredient Axitinib, ATC L01EK01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Ref T-1126177153·via Bekanntmachungsservice

VALUE

--

DEADLINE

Apr 30, 2027

TIME LEFT

190 days

Open house discount contracts for the active ingredient Oxycodone and Naloxone, ATC N02AA55

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Ref T-1101286360·via Bekanntmachungsservice

VALUE

--

DEADLINE

Apr 30, 2027

TIME LEFT

190 days

Conclusion of non-exclusive drug rebate agreements according to § 130a para. 8 SGB V by means of an open-house model for the active ingredient Denosumab Prolia (WHO ATC code: M05BX04)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Ref T-1154409128·via Bekanntmachungsservice

VALUE

--

DEADLINE

May 31, 2027

TIME LEFT

221 days

Medical Equipment

Medical Equipment

Procurement of 17 intensive care ventilators

EUREGIO-KLINIK Nordhorn - New Angiography Building - Delivery and Installation of a Biplane Angiography System

Medical furniture LV.381

36. Generic tender (1st)

36. Generics tender (2/3)

36. Generic tender (antibiotics)

Open House Original Discount Contracts 2025-19 - Tafamidis

Open House Original Discount Contracts 2025-05 - Emtricitabine/Tenofovir disoproxil/Rilpivirine (drug combination)

Conclusion of non-exclusive drug discount agreements according to § 130a para. 8 SGB V by means of an open house model for the active ingredient pancreatin (WHO ATC code: A09AA02)

Open-House-Biologika-Discount-Contracts 2025-25 - Aflibercept (ATC: S01LA05; Strength: 40 mg/ml)

Conclusion not excl. Arzneimittel-Rabattvereinb. according to § 130a Abs. 8 SGB V in the form of an open-house model for the active ingredient Certolizumab pegol (ATC code according to WHO: L04AB05)

Open house drug discount contracts for the active ingredient Dimethyl Fumarate, ATC L04AX07

Conclusion of a non-exclusive discount agreement according to § 130a para. 8 SGB V for the active ingredient Guselkumab (exclusively strength 100mg), ATC L04AC16 for the period 01.12.2026 - 31.03.2027

Conclusion of a non-exclusive discount agreement according to § 130a para. 8 SGB V for the active ingredient Bimekizumab, ATC L04AC21 for the period 01.10.2026 - 31.03.2027

Open-house drug discount agreements according to § 130a para. 8c SGB V for the KV region Berlin

Open-house drug discount agreements according to § 130a para. 8c SGB V for the KV region Mecklenburg-Vorpommern

Open-house drug discount agreements according to § 130a para. 8c SGB V for the KV region Brandenburg

Open-house discount agreements 2025-01

Conclusion not excl. drug rebate agreements according to § 130a para. 8 SGB V by means of an open-house model for the active ingredient Oxycodone/Naloxone (WHO ATC code: N02AA55)

Open House Discount Contracts 2025-02

Open house drug discount contracts for the active ingredient Ticagrelor, ATC B01AC24

Open house discount agreements for the active ingredient Axitinib, ATC L01EK01

Open house discount contracts for the active ingredient Oxycodone and Naloxone, ATC N02AA55

Conclusion of non-exclusive drug rebate agreements according to § 130a para. 8 SGB V by means of an open-house model for the active ingredient Denosumab Prolia (WHO ATC code: M05BX04)